Recombinant Human PTP1B Protein，His & Myc

PTP1B, or protein tyrosine phosphatase 1B, is a crucial enzyme involved in the regulation of various signaling pathways, particularly those related to insulin and other growth factor receptor signaling. Since its discovery, PTP1B has gained significant attention due to its role in insulin signaling and glucose homeostasis, making it a potential therapeutic target for metabolic disorders, including type 2 diabetes and obesity. The study of PTP1B has revealed its localization in the endoplasmic reticulum and its involvement in the dephosphorylation of key tyrosine residues on insulin receptor substrates. This action negatively influences insulin signaling, thereby modulating glucose uptake and metabolic response. Furthermore, PTP1B has been implicated in the development of resistance to insulin, fostering an environment conducive to the onset of diabetes. Researchers have been focused on developing PTP1B inhibitors as a promising approach for enhancing insulin action and ameliorating insulin resistance. The generation of recombinant PTP1B protein has facilitated biochemical assays, structural studies, and high-throughput screening of potential inhibitors, advancing our understanding of its function and providing insights into novel therapeutic strategies. Overall, the research surrounding PTP1B and its recombinant protein forms has profound implications for the treatment of metabolic diseases, highlighting the importance of targeted interventions in signaling pathways.